the aid library

LIST OPTIONS

Filter

3069

Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2025

UNAIDS (2024) C1

The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions... more

Download (130)

View PDF (150)

Climate risk country profile Ecuador

World Bank Group (2021) C1

This profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile synthesizes most relevant data and information on climate change, disaster risk reduction, and adaptation actions and policies at the country level. The country profile se... more

Download (180)

View PDF (214)

Tobacco product regulation

World Health Organization; Together lets beat Tobacco (2018) C_WHO

Building laboratory testing capacity

Download (38)

View PDF (30)

Neglected Disease Research and Development: The Higher Cost of Lower Funding

G-Finder (2023) CC

Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go... more

Download (244)

View PDF (312)

Hammer-blow: How the conflict in Ukraine will have a catastrophic impact on displaced communities in crises

Norwegian Refugee Council (2022) CC

Global food insecurity has markedly increased over the last two-years due to conflict, economic and political instability, displacement, environmental degradation and disasters, and major disruptions to global food systems because of the Covid-19 pandemic. In 2021, levels of hunger surpassed all pre... more

External Link

A toolkit for national dengue burden estimation

Brady, O. J. et all. WHO (2018) CC

The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden of dengue.

Download (108)

View PDF (94)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (138)

View PDF (185)

The Covid-19 Pandemic and Conflict Dynamics in Syria

Asseburg, M.; H. Azizi, G. Dalay and M. Pieper Stiftung Wissenschaft und Politik (2020) CC

Neither a Turning Point Nor an Overall Determinant Nine years into the (civil) war, Syria is in an extraordinarily poor position to confront the Covid-19 pandemic. Instead of the pandemic leading towards the uniting of local, regional, and international actors involved in Syria around a common purp... more

Download (429)

View PDF (341)

Trastorno de personalidad límite en adolescentes

L. Cailhol; L. Gicquel; J.-P. Raynaud IACAPAP (2018) C2

Otros trastornos Capítulo H.4 Editores: Laura Borredá Belda, Matías Irarrázaval & Andres Martin Traductores: Sara Diego Castaño, Laura Álvarez Bravos, Rebeca Santonja & Beatriz Ortega

Download (393)

View PDF (473)

Financing Global Health 2018: Countries and Programs in Transition

Institute for Health Metrics and Evaluation (IHME) Institute for Health Metrics and Evaluation (IHME) (2019) C2

This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides the most up-to-date estimates of development assistance for health, domestic spending on health, health spending on two key infectious diseases – malaria and HIV/AIDS – and fut... more

External Link

Determinants of anemia among women and children in Nepal and Pakistan: An analysis of recent national survey data

Harding, Kassandra L.; Aguayo, Victor M. et al. (2017) CC

Maternal Child Nutrition. 2017;e12478
This paper analyzes individual level and household level determinants of anemia among children and women in Nepal and Pakistan. Applying multivariate modified Poisson models to recent national survey data, we find that the prevalence of anemia was significa... more

Download (1292)

View PDF (1620)

India: Five Years (2009-2014) Achievements & New Initiatives

National health Mission; Ministry of Health and Family Welfare Government of India (2014) C1

Download (256)

View PDF (402)

Burden of disease attributable to unsafe drinking-water, sanitation and hygiene: 2019 update

World Health Organisation (WHO) (2023) C_WHO

The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o... more

External Link

Treatment of anxiety disorders

B.Bandelo, S. Michaelis, D. Wedekind (2017) CC

Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.

Download (713)

View PDF (641)

Medicines Patents, Access and Innovation

Brot für die Welt (2016) C2

The growing challenges for people in low and middle-income countries to access new medicines. Analysis 58

Download (241)

View PDF (251)

Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019)

World Health Organization WHO (2020) C_WHO

Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report... more

Download (952)

View PDF (1215)

Community-based rehabilitation for people with disabilities

V.Lemmi; H. Kuper and K. Blanchett , et al. International I nitiativ e for Impact E valuation (3ie) (2016) C1

Systematic Review Summary 4

Download (143)

View PDF (165)

Reorganização e Expansão Progressiva dos Serviços de Saúde para Resposta à Pandemia de COVID-19

Pan American Health Organization PAHO, World Health Organization WHO (2020) C_WHO

Este documento traz recomendações para a implementação de planos operacionais em redes de serviços de saúde, tanto na atenção primária (incluindo assistência domiciliar) quanto em hospitais, para reorganizar a entrega dos serviços e ganhar eficiência na gestão e expansão da oferta de l... more

Download (1574)

View PDF (1963)

PIH Guide to the Medical Management of MDR-TB

USAID; TB Care; DRTB Training Network (2014) C1

This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.

Download (184)

View PDF (214)

Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2

World Health Organization WHO (2021) C_WHO

Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato... more